lvrachЛечащий ВрачLechaschi Vrach1560-51752687-1181lvrach-546Research ArticleСтатьиСовременные тенденции в лечении остеоартрита. Внутрисуставное применение производных гиалуроновой кислотыModern trends in osteoarthritis treatment. Intra-articular application of hydraulic acid preparationsНайманнА. И.NaimannA. I.Naimann.a@mail.ruООО «Клиника Экспертных Технологий»Russian Federation201823062021074242Copyright © Найманн А.И., 20212021Найманн А.И.Naimann A.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.lvrach.ru/jour/article/view/546

Статья представляет собой подробный разбор механизмов действия производных гиалуроновой кислоты для внутрисуставной терапии остеоартрита, включающий в себя сравнительную оценку различных характеристик средств данной группы, таких как эластичность, упругость, молекулярная масса. Особое внимание уделяется протезам синовиальной жидкости.

The article presents detailed analysis of action mechanisms of hydraulic acid derivatives for intra-articular therapy of osteoarthritis, which includes comparative assessment of different characteristics of preparations from this group, such as elasticity, resilience, molecular mass. Special attention is paid to synovial liquid prostheses. 

КоллоквиумРевматологияГиалуроновая кислотаОстеоартритПротезы синовиальной жидкостиhydraulic acidosteoarthritissynovial liquid prosthesesReferencesAltman R. D. Status ot hyaluronan supplementation therapy in osteoarthritis // Curr Rheumatol Rep. 2003; 5: 7–14.Altman R. D. Status ot hyaluronan supplementation therapy in osteoarthritis // Curr Rheumatol Rep. 2003; 5: 7–14.Balazs E. A., Denlinger J. L. Clinical uses of hyaluronan // Ciba Found Symp. 1989; 143: 265–275.Balazs E. A., Denlinger J. L. Clinical uses of hyaluronan // Ciba Found Symp. 1989; 143: 265–275.Fraser J. R., Laurent T. C., Laurent U. B. Hyaluronan: its nature, distribution, functions and turnover // J lntern Md. 1997; 242: 27–33.Fraser J. R., Laurent T. C., Laurent U. B. Hyaluronan: its nature, distribution, functions and turnover // J lntern Md. 1997; 242: 27–33.Balazs E. A., Denlinger J. L. Viscosupplementation: a new concept in the treatment of osteoarthritis // J Rharmatol Suppl. 1993; 39: 3–9.Balazs E. A., Denlinger J. L. Viscosupplementation: a new concept in the treatment of osteoarthritis // J Rharmatol Suppl. 1993; 39: 3–9.Pasquali Ronchetti I., Guerra D., Taparelli F. el al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) osteoarthritis // Rheumatobgy. 2001; 40: 158–169.Pasquali Ronchetti I., Guerra D., Taparelli F. el al. Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) osteoarthritis // Rheumatobgy. 2001; 40: 158–169.Weiss C., Band P. Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle // Clin Podiatr Med Surg. 1995; 12: 497–517.Weiss C., Band P. Musculoskeletal applications of hyaluronan and hylan. Potential uses in the foot and ankle // Clin Podiatr Med Surg. 1995; 12: 497–517.Wobig M., Dickhut A., Maier R., Vetter G. Viscosupplementation with hylan G–F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee // Clin Ther. 198: 20: 410–423.Wobig M., Dickhut A., Maier R., Vetter G. Viscosupplementation with hylan G–F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee // Clin Ther. 198: 20: 410–423.Altman R. D., Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group [published correction appears in J Rheumatol. 1999; 26: 12 16] // J Rheumatol.1998; 25: 2203–2212.Altman R. D., Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group [published correction appears in J Rheumatol. 1999; 26: 12 16] // J Rheumatol.1998; 25: 2203–2212.

The authors declare that there are no conflicts of interest present.